BioCentury
DATA GRAPHICS | Product Development

Daily Chart: Inovio joins COVID-19 vaccine developers showing mouse immunogenicity data

May 21, 2020 12:44 AM UTC

Inovio reported mouse immunogenicity data from its COVID-19 vaccine that include lung detection of anti-SARS-CoV-2 antibodies, hinting at protectiveness. While direct comparison to mouse data from other COVID-19 vaccines is difficult, the findings put the Inovio vaccine roughly on par with University of Oxford’s.

Inovio Pharmaceuticals Inc. (NASDAQ:INO), which gained $1.23 to $15.79 Wednesday, reported in Nature Communications that a single administration of INO-4800 induced serum anti-spike antibody titers of about 2,000 in mice. Two immunizations resulted in serum neutralizing titers of 128. ...